Clinical trial
Medical Research Council (MRC) Working Party on Leukaemia in Children UK…
NCT00222612 · University of Oxford, Other · Unknown status
Key facts
| NCT number | NCT00222612 |
|---|---|
| Title | Medical Research Council (MRC) Working Party on Leukaemia in Children UK National Acute Lymphoblastic Leukaemia (ALL) Trial: UKALL 2003 |
| Official title | Medical Research Council Working Party on Leukaemia in Children UK National Acute Lymphoblastic Leukaemia (ALL) Trial: UKALL 2003 |
| Lead sponsor | University of Oxford, Other |
| Collaborators | Medical Research Council |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Acute Lymphoblastic Leukemia |
| Intervention type | Drug, Other |
| Interventions | Reduced intensification, Standard childhood UK ALL protocol, Intensified treatment including Capizzi maintenance |
| Enrollment | 2,100 |
| Start date | Oct 1, 2003 |
| Primary completion | Aug 1, 2013 |
| Completion | Aug 1, 2013 |
| First posted | Sep 22, 2005 |
| Last update posted | Feb 3, 2010 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: